Potential of nanoparticles encapsulated drugs for possible inhibition of the antimicrobial resistance development

The immune system is a dynamic network of cells and cytokines are the major mediators of immune responses which combat pathogens. Based on the cytokine production, effector T cells differentiate into subsets known as Th1, Th2, Th17, or Treg. This system serves as a barrier to intracellular pathogens...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biomedicine & pharmacotherapy 2021-09, Vol.141, p.111943-111943, Article 111943
Hauptverfasser:	Pandey, Ramendra Pati, Mukherjee, Riya, Priyadarshini, Anjali, Gupta, Archana, Vibhuti, Arpana, Leal, Elcio, Sengupta, Utpal, Katoch, Vishwa Mohan, Sharma, Pawan, Moore, Catrin E., Raj, V. Samuel, Lyu, Xiaoming
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - chemical synthesis Drug Carriers - administration & dosage Drug Carriers - chemical synthesis Drug Development - methods Drug Development - trends Drug Resistance, Bacterial - drug effects Drug Resistance, Bacterial - physiology Humans Immune system Intracellular pathogens Nanoparticles Nanoparticles - administration & dosage Nanoparticles - chemistry Oxidative stress Oxidative Stress - drug effects Oxidative Stress - physiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!